Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials,Epilepsia

当前位置： X-MOL 学术 › Epilepsia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials
Epilepsia ( IF 6.6 ) Pub Date : 2021-07-15 , DOI: 10.1111/epi.16974
Jennifer Madan Cohen ₁ , Daniel Checketts ₂ , Eduardo Dunayevich ₃ , Boudewijn Gunning ₄ , Ann Hyslop ₅ , Deepak Madhavan ₆ , Vicente Villanueva ₇ , Marta Zolnowska ₈ , Sameer M Zuberi ₉

Affiliation

We conducted a post hoc analysis of two randomized controlled trials, GWPCARE1 (NCT02091375) and GWPCARE2 (NCT02224703), to estimate the time to onset of cannabidiol (CBD) treatment effects (seizure reduction and adverse events [AEs]) in patients with Dravet syndrome (DS).

中文翻译：

Dravet 综合征中大麻二酚治疗效果的起效时间：两项随机对照试验的分析

我们对两项随机对照试验 GWPCARE1 (NCT02091375) 和 GWPCARE2 (NCT02224703) 进行了事后分析，以估计 Dravet 综合征患者中大麻二酚 (CBD) 治疗效果（癫痫发作减少和不良事件 [AE]）的起效时间（DS）。

更新日期：2021-08-29

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11